Wenxue Guan

机构：Beijing Tongren Hospital, Capital Medical University, Peking University, Peking University People's Hospital · ORCID：0000-0002-8412-8479

发表论文 11 篇 · 总被引 169 次 · h-index 7

代表论文

• Targeting Bruton’s tyrosine kinase in vitreoretinal lymphoma: an open-label, prospective, single-center, phase 2 study (2022 · Experimental Hematology and Oncology · 被引 47)
• Targeting Bruton Tyrosine Kinase for the Treatment of Vitreoretinal Lymphoma: Report of 11 Consecutive Patients (2021 · Blood · 被引 33)
• Spectral‐domain optical coherence tomography biomarkers in vitreoretinal lymphoma (2022 · Clinical and Experimental Ophthalmology · 被引 20)
• Targeting Bruton Tyrosine Kinase With Zanubrutinib for Treatment of Vitreoretinal Lymphoma: Report of 3 Cases (2021 · Frontiers in Oncology · 被引 20)
• Development of Diagnostic Recommendations for Vitreoretinal Lymphoma (2023 · Ocular Immunology and Inflammation · 被引 12)
• Retinal G‐protein‐coupled receptor deletion exacerbates AMD ‐like changes via the PINK1 –parkin pathway under oxidative stress (2024 · The FASEB Journal · 被引 9)